ADAR1 Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.72M | Sell |
1,205,101
-266,486
| -18% | -$1.71M | 1.18% | 22 |
|
|
2025
Q1 | $5.21M | Buy |
+1,471,587
| New | +$5.21M | 0.97% | 29 |
|
|
2024
Q4 | – | Sell |
-220,906
| Closed | -$716K | – | 205 |
|
|
2024
Q3 | $716K | Buy |
220,906
+113,600
| +106% | +$368K | 0.12% | 91 |
|
|
2024
Q2 | $204K | Buy |
107,306
+68,448
| +176% | +$130K | 0.04% | 135 |
|
|
2024
Q1 | $110K | Sell |
38,858
-38,700
| -50% | -$110K | 0.03% | 132 |
|
|
2023
Q4 | $1.14M | Buy |
+77,558
| New | +$1.14M | 0.41% | 39 |
|